Skip to content

US · OSCR · MEDICAL - HEALTHCARE PLANS

Oscar Health, Inc. (OSCR) intrinsic value and stock valuation

$24.73as of 2026-11-21 · Mkt cap 7.23B

Data updated · price as of 2026-11-21

Strongly undervaluedIC value is more than 50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Oscar Health, Inc. DCF and intrinsic value

InvestorsCraft values OSCR with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from OSCR’s statements →

Oscar Health, Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Healthcare Plans New York City, NY 10013 hioscar.com

How the business is doing

Fiscal 2019–2025, USD

Revenue
$11.7B+81.8% 5y CAGRd
20192025
Net income
-$-443.15M
20192025
Free cash flow
$1.06B+38.4% 5y CAGRd
20192025
Total equity
$980.7M
20192025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2019–2025, USD
20252024202320222021
Revenue$11.7B$9.18B$5.86B$4.13B$1.92B
Operating income-$-396.36M$57.3M-$-235.62M-$-610.08M-$-570.58M
Net income-$-443.15M$25.4M-$-270.73M-$-606.27M-$-572.61M
EPSd-$-1.69M$95.7K-$-1.22M-$-2.85M-$-3.2M
Operating cash flow$1.09B$978.2M-$-272.16M$380.4M-$-181.75M
Capital expenditure-$-36.37M-$-27.9M-$-25.58M-$-29.01M-$-25.89M
Free cash flow$1.06B$950.3M-$-297.74M$351.3M-$-207.63M
Total assets$6.33B$4.84B$3.6B$4.53B$3.32B
Total debt$430.1M$299.6M$298.8M$298M$0.00
Net debt-$-2.34B-$-1.23B-$-1.57B-$-1.26B-$-1.1B
Total equity$980.7M$1.02B$806.1M$892.4M$1.39B
Cash and short-term investments$3.99B$2.15B$2.56B$2.96B$1.69B
Income statement
20252024202320222021
Revenue$11.7B$9.18B$5.86B$4.13B$1.92B
Cost of revenue$10B$7.33B$4.64B$0.00$0.00
Gross profit$1.68B$1.84B$1.22B$4.13B$1.92B
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$2.05B$0.00$0.00$1.42B$265.1M
Other expenses$28.9M$1.79B$1.46B$3.32B$2.23B
Operating expenses$2.08B$1.79B$1.46B$4.74B$2.49B
Cost and expenses$12.1B$9.12B$6.1B$4.74B$2.49B
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$17.6M$23.7M$24.6M$22.6M$4.72M
Depreciation and amortization$28.9M$32.2M$30.7M$15.3M$14.6M
Ebitda-$-391.05M$89.3M-$-212M-$-572.17M-$-551.25M
Operating income-$-396.36M$57.3M-$-235.62M-$-610.08M-$-570.58M
Total other income/expenses, net-$-40.94M-$-23.84M-$-31.68M$0.00$0.00
Income before tax-$-437.3M$33.4M-$-267.3M-$-610.08M-$-570.58M
Income tax expense$5.61M$7.3M$3.29M-$-520K$850K
Net income-$-443.15M$25.4M-$-270.73M-$-606.27M-$-572.61M
Weighted average shares outstanding$262.4M$240.4M$221.7M$212.5M$179M
Weighted average diluted shares outstanding$262.4M$265.9M$221.7M$212.5M$179M
Balance sheet
20252024202320222021
Cash and short-term investments$3.99B$2.15B$2.56B$2.96B$1.69B
Net receivables$442.6M$315.9M$494.4M$49.9M$611.1M
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$4.61B$2.85B$2.07B$4.12B$2.77B
Property, plant and equipment, net$88.4M$66.8M$61.9M$59.9M$46.6M
Goodwill and intangible assets$0.00$0.00$0.00$0.00$0.00
Long-term investments$1.47B$1.82B$365.3M$1.4B$844.5M
Total non-current assets$1.71B$2B$1.53B$405.1M$555.7M
Total assets$6.33B$4.84B$3.6B$4.53B$3.32B
Accounts payable-$-99.75M$1.4B$1.03B$1.37B$718.8M
Short-term debt$0.00$0.00$0.00$0.00$0.00
Deferred revenue$0.00$0.00$0.00$0.00$75M
Total current liabilities$4.86B$3.17B-$-175.28M$3.26B$1.62B
Long-term debt$430.1M$299.6M$298.8M$298M$0.00
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$482.1M$360.8M$2.97B$370.3M$2.29B
Capital lease obligations$0.00$0.00$0.00$0.00$0.00
Total liabilities$5.34B$3.82B$2.8B$3.63B$1.93B
Common stock$0.00$0.00$0.00$0.00$0.00
Retained earnings-$-3.29B-$-2.85B-$-2.88B-$-2.61B-$-2B
Accumulated other comprehensive income (loss)$18M-$-1.83M$1.31M-$-9.71M-$-3.67M
Total equity$980.7M$1.02B$806.1M$892.4M$1.39B
Total investments$2.69B$2.44B$1.06B$2.79B$1.43B
Total debt$430.1M$299.6M$298.8M$298M$0.00
Net debt-$-2.34B-$-1.23B-$-1.57B-$-1.26B-$-1.1B
Cash flow statement
20252024202320222021
Net income-$-442.9M$26.1M-$-270.59M-$-609.55M-$-571.43M
Depreciation and amortization$28.9M$32.2M$30.7M$15.3M$14.6M
Stock-based compensation$87.7M$109.8M$159.7M$112.3M$86.3M
Change in working capital$1.46B$838.9M-$-192.09M$855M$247.7M
Accounts receivable$98.6M-$-177.52M$636.2M-$-551.15M$80.5M
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable$167.7M$133.1M-$-395.81M$280.2M-$-39.46M
Net cash provided by operating activities$1.09B$978.2M-$-272.16M$380.4M-$-181.75M
Investments in property, plant and equipment-$-36.37M-$-27.9M-$-25.58M-$-29.01M-$-25.89M
Acquisitions, net$0.00$0.00$0.00$0.00$7.23M
Net cash used for investing activities-$-241.06M-$-1.39B$577.2M-$-226.52M-$-774.51M
Common stock issued$55M$68.4M$3.96M$1.3M$1.35B
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$399.2M$68.4M$6.45M$301.1M$1.24B
Net change in cash$1.25B-$-340.85M$311.5M$454.9M$282.5M
Cash at end of period$2.8B$1.55B$1.89B$1.58B$1.13B
Operating cash flow$1.09B$978.2M-$-272.16M$380.4M-$-181.75M
Capital expenditure-$-36.37M-$-27.9M-$-25.58M-$-29.01M-$-25.89M
Free cash flow$1.06B$950.3M-$-297.74M$351.3M-$-207.63M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Oscar Health, Inc.

        Oscar Health, Inc. operates as a health insurance provider across the United States. Its offerings include various health plans such as those for individuals and families, small businesses, and Medicare Advantage options. The company also features "+Oscar," a proprietary technology platform designed to facilitate engagement between healthcare providers, payers, and their members or patients. Additionally, Oscar Health provides reinsurance solutions. Originally established as Mulberry Health Inc., the firm officially changed its name to Oscar Health, Inc. in January 2021. It was founded in 2012 and maintains its main office in New York, New York.

        CEO
        Mark Thomas Bertolini
        Employees
        2.31K
        Beta
        2.34

        Explore

        Frequently asked questions

        What is the intrinsic value of Oscar Health, Inc. (OSCR)?

        Oscar Health, Inc. (OSCR) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is OSCR undervalued?

        OSCR trades at a price of $24.73 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.